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Purpose: To verify the intrafractional tracking accuracy in infrared (IR) marker-based 36 
hybrid dynamic tumour tracking irradiation (“IR Tracking”) with the Vero4DRT. 37 
Materials and Methods: The gimballed x-ray head tracks a moving target by predicting its 38 
future position from displacements of IR markers in real-time. Ten lung cancer patients 39 
who underwent IR Tracking were enrolled. The 95
th
 percentiles of intrafractional 40 
mechanical (
95
MiE ), prediction (
95
PiE ), and overall targeting errors (
95
TiE ) were calculated 41 
from orthogonal fluoroscopy images acquired during tracking irradiation and from the 42 
synchronously acquired log files. 43 
Results: Averaged intrafractional errors were (left-right, cranio-caudal [CC], 44 
anterior-posterior [AP]) = (0.1 mm, 0.4 mm, 0.1 mm) for 
95
MiE , (1.2 mm, 2.7 mm, 2.1 mm) 45 
for 
95
PiE , and (1.3 mm, 2.4 mm, 1.4 mm) for 
95
TiE . By correcting systematic prediction 46 
errors in the previous field, the 
95
PiE  was reduced significantly, by an average of 0.4 mm 47 
in the CC (p < 0.05) and by 0.3 mm in the AP (p < 0.01) directions. 48 
Conclusions: Prediction errors were the primary cause of overall targeting errors, whereas 49 
mechanical errors were negligible. Furthermore, improvement of the prediction accuracy 50 
could be achieved by correcting systematic prediction errors in the previous field. 51 
52 





Respiratory motion is one of the factors causing uncertainties during beam delivery, 54 
particularly for thoracic and abdominal tumours [1, 2]. In hypofractionated stereotactic 55 
body radiotherapy for lung cancer patients, addition of a large margin to compensate for 56 
respiratory motion increases the probability of complications [3]. Several techniques, 57 
including forced shallow-breathing, breath-hold, respiratory gating, and dynamic tumour 58 
tracking (DTT), have been proposed to reduce the uncertainties caused by respiratory 59 
motion [1, 2]. Of these methods, recent interest has focused on the DTT technique, which 60 
can reposition the radiation beam dynamically in accordance with the target position. DTT 61 
can minimise the internal uncertainties without a burden on the respiration of patients or 62 
prolongation of treatment time. 63 
We have developed an innovative four-dimensional (4D) image-guided 64 
radiotherapy system, the Vero4DRT (MHI-TM2000; Mitsubishi Heavy Industries, Ltd., 65 
Japan, and BrainLAB, Feldkirchen, Germany) [4-10], and used its hybrid DTT irradiation 66 
function [infrared (IR)-marker-based hybrid DTT irradiation (“IR Tracking”)] clinically in 67 
lung cancer patients since September 2011 [10]. In IR Tracking, the position of the target, 68 
indicated by implanted fiducial markers, is calculated from external surrogate signals 69 
through a pre-built prediction model (“4D model”), and the MV x-ray beam is delivered 70 
with real-time monitoring [7, 8, 10-12]. Depuydt et al. showed that the performance of 71 
Vero4DRT’s DTT function was comparable with other clinical DTT systems in phantom 72 
and patient simulation studies [11, 12]. Our group also previously revealed that the 73 
accuracy of the 4D model must be verified before treatment, and margins were required to 74 




compensate for the prediction error in a phantom study [7]; it was concluded that the 75 
accuracy of the 4D model was affected by the baseline drift of respiratory motion [8]. Here, 76 
we verified the intrafractional tracking accuracy of IR Tracking for lung cancer patients 77 
using intrafractional monitoring images and the corresponding log files. 78 
 79 
MATERIALS AND METHODS 80 
The Vero4DRT hybrid dynamic tumour tracking irradiation system 81 
Supplementary Figure 1 (Electronic Appendix) shows a schematic diagram of the 82 
Vero4DRT system. The Vero4DRT has several unique components that facilitate DTT 83 
irradiation: (1) a compact C-band 6-MV x-ray head with a gimbal mechanism, mounted on 84 
an O-ring gantry. The gimballed x-ray head can swing itself in both the pan and tilt 85 
directions, (2) gantry-mounted orthogonal kV x-ray imaging subsystems, consisting of two 86 
sets of x-ray tubes and flat-panel detectors, with a spatial resolution of 0.2 mm at the 87 
isocentre level, and (3) an extended version of the ExacTRAC system that enables real-time 88 
motion monitoring and management for the DTT function [7, 8, 11, 12] with an IR camera 89 
mounted on the ceiling of the treatment room. 90 
 Supplementary Figure 2 shows a schematic diagram of the IR Tracking procedure. 91 
After patient positioning, a 4D model is created using synchronously monitored internal 92 
target motion and an external surrogate signal. The detected target position (Pd) is defined 93 
as the tumour centre-of-mass calculated from the positions of the implanted fiducial 94 
markers on the x-ray images. The relative shift amount between the tumour centre-of-mass 95 
and centroid of the markers’ polyhedron was determined at the end-exhalation phase in the 96 




planning computed tomography. The predicted target position (Pp) is calculated from the 97 
4D model, expressed by a quadratic equation involving two variables, the position and 98 
velocity of the IR markers. The positions of the IR markers are predicted linearly from the 99 
past motion to compensate for the DTT system delay [11]. Details of the prediction model 100 
are described in the Supplementary Materials section. In this 4D-modelling phase, the 101 
peak-to-peak amplitude of the detected target motion (A) and the mean (μ) and standard 102 
deviation (SD) of the absolute 4D-modelling error (E4DM), defined as the absolute 103 
difference between the Pp and Pd, are calculated along each axis automatically. During 104 
beam delivery, the future 3D target position is calculated from the displacements of the IR 105 
markers using the 4D model, and then the corresponding tracking angle is transferred 106 
continuously to the gimballed x-ray head. Additionally, circles with a user-defined radius 107 
around the predicted positions of the fiducial markers (tolerance circles) are displayed on 108 
the monitoring images as a benchmark in re-modelling. When the fiducial markers are 109 
deviated systematically from the tolerance circles, re-modelling should be performed 110 
during each treatment session (Fig. 1). 111 
 112 
Patient characteristics and treatment planning 113 
Ten lung cancer patients who underwent IR Tracking in an Institutional Review 114 
Board-approved trial were included in the present study. Patient selection criteria were 115 
based on our stereotactic body radiation therapy protocol and written informed consent for 116 
the present study was obtained from each patient [3, 10]. Three or more 1.5-mm-diameter 117 
gold markers (Olympus Co., Tokyo, Japan) were implanted around the lung tumour 118 




transbronchially 1–2 weeks before treatment planning. Table 1 shows the characteristics of 119 
the patients and treatment planning. We performed a dry-run treatment session prior to 120 
treatment planning to assess the characteristics of respirations and to identify 121 
patient-specific planning target volume (PTV) margins [7, 9]. The median of A was 2.8 mm 122 
in the left-right (LR), 15.8 mm in the cranio-caudal (CC), and 4.3 mm in the 123 







) was 0.6 mm in the LR, 1.9 mm in the CC, and 0.7 mm in the AP 125 
directions. Patient-specific PTV margins of 5.0–9.0 mm were added to the tumour along 126 
each axis to compensate for intra- and interfractional uncertainties in IR Tracking [7, 9, 13]. 127 
Supplementary Figure 3 shows the definition of the patient-specific PTV margins. The 128 
intra- and interfractional uncertainties were classified into systematic and random 129 
components. The patient-specific PTV margins were then calculated for each axis using the 130 
formula in Supplementary Figure 3. Prescribed doses of 48 or 56 Gy were specified to 131 
isocentre in four fractions. Treatment plans included 6-8 non-coplanar fields, with a dose 132 
rate of 500 MU/min. 133 
 134 
Data acquisition during beam delivery 135 
During beam delivery, the target and fiducial markers were monitored using orthogonal kV 136 
x-ray imaging subsystems at 1 Hz. The predicted target positions and tracking angles of the 137 
gimballed x-ray head were recorded in log files at 60 and 200 Hz, respectively. In total, 138 
9268 paired images (~30 paired images per field) and corresponding log files were 139 
acquired. 140 





Verification of intrafractional tracking accuracy 142 
Intrafractional tracking accuracy was verified by the Pd from the fluoroscopic images and 143 
the corresponding Pp and the tracked target position, calculated from the synchronously 144 
acquired log files. Supplementary Figure 4 shows the geometric point of the tracked target 145 
position at the depth of the Pd (Pt,d). The tracked target position at the depth of the Pp (Pt,p), 146 
was calculated similarly. Intrafractional mechanical (iEM), prediction (iEP), and overall 147 
targeting errors (iET) were defined as the differences between Pt,p and Pp, Pp and Pd, and Pt,d 148 
and Pd, respectively. Details of the calculation process are described in the Supplementary 149 
Materials section. 150 
 The 95
th
 percentiles of the absolute iEM (
95
MiE ), iEP (
95
PiE ), and iET (
95
TiE ) during 151 
the treatment course were then calculated using the intrafractional monitoring images and 152 







 during the dry-run treatment session and 
95
PiE  or 
95
TiE  154 
during the treatment course. To further improve the prediction accuracy, the corrected 
95
PiE  155 
was recalculated retrospectively by subtracting the systematic (i.e. signed overall mean) iEP 156 
in the previous field excluding the first field after the 4D modelling. A paired t-test with a 157 
0.05 significance level was performed for statistical analysis. 158 
 159 
RESULTS 160 






TiE , and corrected 
95
PiE  for 10 lung cancer patients. 161 




Averaged intrafractional tracking errors were (LR, CC, AP) = (0.1 mm, 0.4 mm, 0.1 mm) 162 
for 
95
MiE , (1.2 mm, 2.7 mm, 2.1 mm) for 
95
PiE , and (1.3 mm, 2.4 mm, 1.4 mm) for 
95
TiE . 163 








PiE  (LR, CC, 164 
AP) = (0.73 [p = 0.017], 0.82 [p = 0.003], 0.96 [p = 0.000]) or 
95
TiE  (LR, CC, AP) = (0.69 165 
[p = 0.028], 0.77 [p = 0.010], 0.90 [p = 0.001]). As shown in Table 2, 
95
PiE  was the 166 
primary cause of 
95
TiE , while 
95
MiE  was negligible. The 
95
TiE  was fully covered by the 167 
PTV margin, including the geometric variations between the tumour and fiducial markers. 168 
Figure 2 (a) shows representative probability histograms in the positional error in the CC 169 
direction for the first patient who underwent IR Tracking (Patient No. 1). 
95
TiE  was 170 
2.3 mm for this patient. 171 
A maximum 
95
TiE  of 4.1 mm was observed for Patient No. 7 in the CC direction. 172 








PiE  [LR, CC, and AP = 173 
1.6, 1.5, and 1.6 mm, respectively] due to a baseline drift during beam delivery. Meanwhile, 174 
the averaged differences for the other patients were 0.3, 0.6, and 0.7 mm for the LR, CC, 175 
and AP directions, respectively. By correcting the systematic prediction errors in the 176 
previous field, however, 
95
PiE  decreased, from 4.1 to 2.7 mm, for this patient in the CC 177 
direction [Fig. 2 (b)]. The maximum reductions in 
95
PiE  were observed in this patient (LR, 178 
CC, AP) = (1.4 mm, 1.4 mm, 0.9 mm). For the entire population, the corrected 
95
PiE  was 179 
improved significantly by an average of 0.4 mm in the CC (p < 0.05) and by 0.3 mm in the 180 
AP (p < 0.01) directions. 181 






The Vero4DRT tracks a moving target in real-time using the orthogonal gimballed x-ray 184 
head. In the present study, we established a verification methodology for the intrafractional 185 
mechanical, prediction, and overall targeting accuracy in each axis during the treatment 186 
course. The 3D coordinates of the intrafractional tracked target position were calculated 187 
based on the MV x-ray beam orientation using intrafractional monitoring images and the 188 
corresponding log files. 189 
 We verified the intrafractional tracking accuracy for 10 lung cancer patients who 190 
underwent IR Tracking with real-time monitoring. Vero4DRT users can monitor the moving 191 
target, fiducial markers, and tolerance circles with its predicted position using orthogonal 192 
kV x-ray imaging subsystems during beam delivery. At our institution, the radius of the 193 
tolerance circles is set to 3 mm, and the 4D model is re-modelled when the monitored 194 
fiducial markers’ positions are displaced systematically from the tolerance circles due to 195 
baseline drift (Fig. 1). By re-modelling the 4D model, while an 
95
TiE  of less than 3 mm 196 
was achieved for nine patients (90%), one patient (Patient No. 7) showed a large 
95
TiE  of 197 
greater than 3 mm. The 4D model was updated once during the treatment session for 198 
Patient No. 7. However, this patient required additional re-modelling. In IR Tracking, the 199 
predominant cause of overall targeting errors was prediction errors. The position and 200 
velocity of IR markers involved in the 4D model were predicted linearly from past IR 201 
marker motion [8]. Thus, prediction uncertainty of the peak position sometimes 202 
overestimated the predicted position of the IR marker and the 4D model enforced a large 203 




amplitude of respiration motion (Supplementary Figure 5). In this case, the mechanical 204 
response delay of the gimballed x-ray head reduced the impact of the prediction error on 205 
the overall targeting error. Thus, the overall targeting errors were sometimes smaller than 206 






 and 207 
95
PiE  or 
95
TiE , indicating that intrafractional prediction or overall targeting errors during 208 
the treatment course could be estimated from 4D modelling errors during the dry-run 209 
treatment session. The 
95
TiE  was fully covered by the PTV margin, including a geometric 210 
variation between the tumour and fiducial markers of 2.5 mm (Tables 1 and 2). When 211 
calculating the PTV margin in IR Tracking, the intra- and interfractional uncertainties 212 
should be considered (Supplementary Figure 3). However, the present recipe of the 213 
patient-specific PTV margin was tentative so as to perform IR Tracking safely. Therefore, 214 
further investigations will be needed to determine the PTV margin size appropriate for IR 215 
Tracking [9]. 216 
The CyberKnife Robotic Radiosurgery System with the integrated Synchrony 217 
Respiratory Tracking System (Accuray, Sunnyvale, CA) substantially reduces the 218 






 was 219 
comparable with results of the Synchrony system. However, the correlation between the 220 
internal target positions and external surrogates can change in the presence of baseline drift, 221 
reducing the accuracy of the prediction model [8, 16]. The Synchrony system periodically 222 
updates the prediction model using the intrafractional monitoring images. Updating the 4D 223 
model in real-time may also improve the prediction accuracy because the internal/external 224 




correlation change or baseline drift in respiration will be corrected. Meanwhile, this is 225 
difficult regarding image processing time and minimum interval of the x-ray acquisition 226 
during beam delivery. The 4D model in IR Tracking includes the parameters of position and 227 
velocity of the IR markers. To update the 4D model, these parameters must be changed. 228 
Thus, a shorter monitoring interval would be necessary. In clinical practice, we re-modelled 229 
the 4D model at least once during treatment to minimise intrafractional uncertainties due to 230 
internal/external correlation change or baseline drift in respiration. However, re-modelling 231 
required additional exposures that were 8.3-16.7 times higher than intrafractional 232 
monitoring [4, 12]. Also, x-ray image-based DTT, another DTT approach with Vero4DRT 233 
[6], would not be an alternative strategy in terms of the difficulty of real-time detection and 234 
excessive imaging doses. In the current study, the overall mean errors of iEP were 235 
calculated from around 30 paired images retrieved in the previous field using the 236 
monitoring function for the intrafractional tracking accuracy verification. Because the 237 
systematic prediction errors resulting from the baseline drift of respiration were reduced by 238 
subtracting the overall mean errors of iEP in the previous field, 
95
PiE  decreased 239 
significantly in the CC and AP directions using the monitoring images during beam delivery. 240 
In the current study, we used all monitoring images to calculate the systematic prediction 241 
errors because iEP varied according to the respiratory phase. However, a triggered x-ray 242 
acquisition based on the respiratory phase would also reduce 
95
PiE  using a small number 243 
of monitoring images because the systematic prediction errors could be corrected by the 244 
averaged iEP at the end-expiratory and end-inspiratory phases. 245 
 246 





We demonstrated that IR Tracking reduced the impact of respiratory motion substantially. 248 
The prediction error was the primary cause of the overall targeting error, while the 249 
mechanical error was negligible. The PTV margin fully covered the intrafractional overall 250 
targeting errors. The 4D modelling errors during a dry-run treatment session were a good 251 
indicator of the prediction and overall targeting errors during the treatment course. 252 
Additionally, further improvement in prediction accuracy was achieved by correcting the 253 
systematic prediction error in the previous field. 254 
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FIGURE LEGENDS 311 
Figure 1. Screen shot of the Vero4DRT during infrared (IR)-marker-based DTT irradiation 312 
(“IR Tracking”). Monitored fiducial markers’ positions were located outside of the 313 
“Tolerance circle” displayed around the predicted fiducial markers’ positions due to the 314 
baseline drift of respiration. 315 
 316 
Figure 2. Probability histograms of positional errors in the cranio-caudal (CC) direction (a) 317 
for the first patient who underwent IR Tracking (Patient No. 1) and (b) for the most 318 
improved patient with intrafractional prediction error (iEP) correction (Patient No. 7). The 319 
Vero4DRT reduced the motion blurring effect caused by respiration. 320 
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Rt  S9 
 
4.6  19.8  4.4  
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2.9  29.6  15.5  
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2.7  9.9  2.3  
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= mean plus two standard deviations of the absolute 4D-modelling 
error during a dry-run treatment session, GTV=gross tumour volume, PTV=planning target volume, LR=left-right, CC=cranio-caudal, 















MiE  [mm]  
95
PiE  [mm]  
95
TiE  [mm]  Corrected 
95
PiE  [mm] 
LR CC AP  LR CC AP  LR CC AP  LR CC AP 
1  0.1 0.3 0.1  0.6 2.7 1.3  0.9 2.3 1.0  0.6 1.9 1.2 
2  0.3 0.7 0.2  1.4 3.4 0.8  1.3 3.0 0.7  1.3 3.1 0.6 
3  0.1 0.4 0.1  0.7 2.5 1.5  0.8 2.2 1.0  0.7 2.7 1.3 
4  0.1 0.4 0.1  0.8 2.0 1.5  0.8 1.7 1.0  0.8 1.7 1.4 
5  0.1 0.1 0.1  1.8 1.5 1.6  1.1 1.5 1.2  1.5 1.5 1.6 
6  0.1 0.3 0.1  1.0 2.5 5.0  1.9 2.3 2.9  0.9 1.8 4.3 
7  0.2 0.8 0.2  2.1 4.1 2.3  1.4 4.1 1.6  0.7 2.7 1.4 
8  0.2 0.4 0.1  2.1 3.2 3.4  2.2 2.8 1.6  2.5 3.2 3.2 
9  0.1 0.3 0.1  0.5 1.6 1.4  0.8 1.4 0.9  0.4 1.3 1.1 
10  0.1 0.3 0.1  1.1 3.0 2.0  1.3 2.9 1.6  1.0 2.7 1.8 









 percentiles of the absolute 




 percentiles of the absolute intrafractional overall targeting error, LR=left-right, 
CC=cranio-caudal, AP=anterior-posterior. 
Figure 1
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Figure 2
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Prediction model of the Vero4DRT 1 
Before irradiation, a prediction model (“4D model”) was created. Infrared (IR) marker 2 
displacements and the implanted fiducial markers’ motions were monitored for 20-40 s 3 
using the IR camera of the ExacTRAC system every 16.7 ms and the orthogonal kV x-ray 4 
imaging subsystems every 80 or 160 ms, respectively. The frame rate of x-ray monitoring 5 
changed automatically depending on IR marker velocity.  6 
After monitoring, two target positions are determined: the detected target position 7 
(Pd) and the predicted target position (Pp). The Pd is defined as the tumour centre-of-mass 8 
calculated from the positions of the implanted fiducial markers on the x-ray images. The 9 
relative shift amount between the tumour centre-of-mass and centroid of the markers’ 10 
polyhedron was determined at the end-exhalation phase in the planning computed 11 
tomography. The positions of the implanted fiducial markers were detected automatically 12 
based on the intensity ratios of the fiducial markers to their surroundings with an accuracy 13 
of 0.2 mm. The Pp is calculated from the predicted position and velocity of IR markers 14 
using the 4D model, expressed as follows: 15 













































































P  16 
where xp, yp, and zp are the predicted target positions in the left-right, cranio-caudal, and 17 
anterior-posterior directions, n is the number of IR markers, and s and v are the predicted 18 
position and velocity of each IR marker in the anterior-posterior direction. The positions of 19 




the IR markers are predicted from the past motion to compensate for DTT system delay. 20 
Parameters of the 4D model (a, b, c, d, and e) were optimised using a least-squares 21 
algorithm so that residual errors between the Pp and Pd were minimised. 22 
During beam delivery, the future 3D target position is predicted from the 23 
displacements of the IR markers using the 4D model, and then the corresponding tracking 24 
angle is transferred continuously to the gimballed x-ray head. 25 
26 




Tracked target position calculated from the tracking angle of the gimballed x-ray head 27 
Intrafractional tracking accuracy was assessed by the detected target position (Pd) from the 28 
fluoroscopic images and the corresponding predicted target position (Pp) and the tracked 29 
target position, calculated from the synchronously acquired log files. The tracked target 30 
position was derived from an intersection of a tracking orientation of the gimballed x-ray 31 
head with a tracked tumour plane. The tracked tumour plane was defined as the 32 
perpendicular plane to the gimbal angle of 0° for each port at the depth of the moving 33 
tumour. The tracked target position, based on Pd (Pt,d), was calculated in the following three 34 
steps: 35 
(1) Conversion of Pd from room to gantry-ring coordinates: 36 

















































where xd, yd, and zd are the detected target positions along the LR, the CC, and the AP 38 
directions in room coordinates, and G and R are the gantry and ring angle, and ud, vd, and 39 
wd (units: mm) are the detected target positions in gantry-ring coordinates corresponding to 40 
xd, yd, and zd. 41 
(2) Calculation of Pt,d at the depth of Pd in gantry-ring coordinates 42 





































where ut,d, vt,d, and wt,d (units: mm) are the tracked target positions in gantry-ring 44 




coordinates at the depth of the detected target position (wt,d). Pθ  and Tθ  are the pan and 45 
tilt angle of the gimballed x-ray head, and 960 mm is the distance from the rotation centre 46 
of the gimballed x-ray head to the isocentre. 47 
(3) Conversion of Pt,d from gantry-ring to room coordinates: 48 






















































where xt,d, yt,d, and zt,d (units: mm) are the tracked target positions in room coordinates. The 50 
tracked target position, based on Pp (Pt,p), at the depth of the predicted target position (wp) 51 
was calculated similarly. 52 
Intrafractional mechanical (iEM), prediction (iEP), and overall targeting errors (iET) 53 
were defined as follows: 54 
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iE  57 
where xt,p, yt,p, and zt,p (units: mm) are the tracked target positions at the depth of the Pp 58 
used for the verification of the mechanical error of the gimballed x-ray head against the 59 




predicted target positions, and xp, yp, and zp (units: mm) are the predicted target positions 60 
used as the tracking commands to the gimballed x-ray head, and xd, yd, and zd (units: mm) 61 
are the detected target positions, and xt,d, yt,d, and zt,d (units: mm) are the tracked target 62 
positions at the depth of the Pd used for the verification of the overall targeting error of the 63 
gimballed x-ray head against the moving tumour. 64 





Supplementary Figure 1. Schematic diagram of the Vero4DRT system. 66 





Supplementary Figure 2. Infrared (IR) marker-based hybrid dynamic tumour tracking 68 
irradiation (“IR Tracking”) procedure. 69 





Supplementary Figure 3. Definition of the patient-specific planning target volume (PTV) margin. 71 





Supplementary Figure 4. The geometric point of the tracked target position (Pt,d) based on the detected target position (Pd) 73 
calculated from orthogonal fluoroscopic images and synchronously acquired log files. 74 





Supplementary Figure 5. Screen shot of the Vero4DRT system during creation of the prediction model (“4D model”). The 76 
right four groups of waves, from top to bottom, show variations in the infrared (IR) markers’ positions in the 77 
anterior-posterior direction and the target positions in the lateral, craniocaudal, and anterior-posterior directions, respectively. 78 
In the graphs of the target position, dark-coloured waves show the detected target position and light-coloured waves show the 79 
predicted target position. 80 
